Invesco’s Ocular Therapeutix OCUL Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2025
Q2
$14.3M Buy
1,538,846
+734,017
+91% +$6.81M ﹤0.01% 1582
2025
Q1
$5.9M Sell
804,829
-85,217
-10% -$625K ﹤0.01% 2065
2024
Q4
$7.6M Buy
890,046
+134,573
+18% +$1.15M ﹤0.01% 2013
2024
Q3
$6.57M Buy
755,473
+709,573
+1,546% +$6.17M ﹤0.01% 2056
2024
Q2
$314K Sell
45,900
-726,466
-94% -$4.97M ﹤0.01% 3462
2024
Q1
$7.03M Buy
772,366
+551,339
+249% +$5.02M ﹤0.01% 2023
2023
Q4
$986K Sell
221,027
-28,912
-12% -$129K ﹤0.01% 2895
2023
Q3
$785K Buy
249,939
+71,390
+40% +$224K ﹤0.01% 2969
2023
Q2
$921K Buy
178,549
+9,397
+6% +$48.5K ﹤0.01% 2928
2023
Q1
$891K Sell
169,152
-96,621
-36% -$509K ﹤0.01% 2936
2022
Q4
$747K Buy
265,773
+129,788
+95% +$365K ﹤0.01% 3061
2022
Q3
$564K Sell
135,985
-36,958
-21% -$153K ﹤0.01% 3174
2022
Q2
$695K Buy
172,943
+12,619
+8% +$50.7K ﹤0.01% 3151
2022
Q1
$794K Buy
160,324
+23,225
+17% +$115K ﹤0.01% 3151
2021
Q4
$955K Buy
137,099
+30,658
+29% +$214K ﹤0.01% 3058
2021
Q3
$1.06M Buy
106,441
+17,923
+20% +$179K ﹤0.01% 3053
2021
Q2
$1.26M Buy
88,518
+26,146
+42% +$371K ﹤0.01% 3016
2021
Q1
$1.02M Sell
62,372
-938,524
-94% -$15.4M ﹤0.01% 3025
2020
Q4
$20.7M Buy
1,000,896
+811,055
+427% +$16.8M 0.01% 1419
2020
Q3
$1.45M Sell
189,841
-412,832
-69% -$3.14M ﹤0.01% 2623
2020
Q2
$5.02M Buy
602,673
+463,694
+334% +$3.86M ﹤0.01% 1987
2020
Q1
$688K Buy
+138,979
New +$688K ﹤0.01% 2902
2019
Q2
Sell
-286,118
Closed -$1.14M 3704
2019
Q1
$1.14M Buy
286,118
+68,470
+31% +$272K ﹤0.01% 2939
2018
Q4
$866K Buy
217,648
+182,510
+519% +$726K ﹤0.01% 3036
2018
Q3
$242K Buy
35,138
+8,955
+34% +$61.7K ﹤0.01% 3610
2018
Q2
$177K Buy
+26,183
New +$177K ﹤0.01% 3693
2015
Q3
Sell
-2,767
Closed -$58K 3901
2015
Q2
$58K Buy
+2,767
New +$58K ﹤0.01% 3961